Study on what drives bronchiectasis worsening
Part of Infections, Lungs & breathing clinical trials.
This study looks at why bronchiectasis gets worse over time. It may help doctors understand the disease better and find better ways to monitor or treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- Your bronchiectasis has been confirmed on a CT scan with high detail (HRCT).
- You have long-term mucus/coughing up phlegm, and you can provide a sputum sample during the study visit.
- You can sign a written consent form after understanding the study.
- Your condition is not “traction bronchiectasis,” and you have the necessary clinical information available for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how bacteria live in the lungs of people with bronchiectasis and how they may adapt over time. It may help researchers understand why infections keep coming back and how to better manage chronic lung colonization.
This study looks at the bacteria in the lungs, infection patterns, and CT scan findings in people with COPD, asthma, or bronchiectasis. It aims to understand these conditions better and may help guide future treatments.
This study follows children (age 5+) and adults with bronchiectasis or ongoing/repeated lung infections to learn what makes infections more likely. It mainly looks at non–cystic fibrosis causes, but may include some related conditions to compare differences.
This study helps doctors understand how severe your bronchiectasis is and predict when you might have flare-ups. You'll have routine tests over 12 months to help researchers learn more about this condition and improve future care.
This study helps doctors identify different types of bronchiectasis (a lung disease where airways are permanently widened and damaged) to better understand how the disease develops and progresses. By following patients over time and collecting medical information, researchers hope to create a system that predicts which patients will worsen and need different treatments.
This study looks at the community of tiny organisms in the lungs (the lung microbiome) in people with bronchiectasis caused by NTM (non-tuberculous mycobacteria). It compares people with positive NTM cultures to people without, to better understand what’s going on in the lungs and why symptoms may differ.
Hear when a new Bronchiectasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.